Treatment-resistant schizophrenia : the relationship between clozapine plasma concentration and clinical outcome

被引：0
|
作者：
Kammoun, I. [1 ]
Jouini, R. [2 ,3 ]
Aissa, A. [1 ]
Boukhchina, R. [1 ]
Zgueb, Y. [1 ]
Khelifa, E. [3 ]
Ouali, U. [1 ]
Jomli, R. [1 ]
Nacef, F. [1 ]
El Hechmi, Z. [3 ]
机构：
[1] Razi Hosp, Psychiat Dept A, Manouba, Tunisia
[2] Razi Hosp, Psychiat F, Manouba, Tunisia
[3] Razi Hosp, Psychiat Dept F, Manouba, Tunisia
来源：
EUROPEAN PSYCHIATRY | 2022年 / 65卷
关键词：
treatment-resistant schizophrenia; clozapine; clozapine plasma concentration;
D O I：
10.1192/j.eurpsy.2022.2039
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EPV1408
引用
收藏
页码：S789 / S789
页数：1
相关论文
共 50 条
  • [31] Clozapine in Treatment-Resistant Schizophrenia and Its Augmentation with Electroconvulsive Therapy in Ultra-Treatment-Resistant Schizophrenia
    Peitl, Vjekoslav
    Puljic, Antonia
    Skrobo, Mislav
    Nadalin, Sergej
    Dunkic, Lidija Fumic
    Karlovic, Dalibor
    BIOMEDICINES, 2023, 11 (04)
  • [32] Exploration of the Barriers to Clozapine Prescribing in Patients with Treatment-Resistant Schizophrenia: A Qualitative Study
    Rezaie L.
    Nazari A.
    Khazaie H.
    Journal of Psychosocial Rehabilitation and Mental Health, 2023, 10 (1) : 45 - 53
  • [33] Clozapine Metabolism is Associated With Absolute Neutrophil Count in Individuals With Treatment-Resistant Schizophrenia
    Willcocks, Isabella R.
    Legge, Sophie E.
    Nalmpanti, Mariana
    Mazzeo, Lucy
    King, Adrian
    Jansen, John
    Helthuis, Marinka
    Owen, Michael J.
    O'Donovan, Michael C.
    Walters, James T. R.
    Pardinas, Antonio F.
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [34] Polypharmacy to Clozapine Monotherapy in Treatment-Resistant Schizophrenia: A Case Report and Review of the Literature
    Bokhari, Syed Ali
    Lutfi, Lubna
    Elnoor, Muhanad
    Mujahid, Beenish
    Osman, Abdelaziz
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [35] Predictors of clozapine discontinuation at 2 years in treatment-resistant schizophrenia
    Iruretagoyena, Barbara
    Castaneda, Carmen Paz
    Mena, Cristian
    Diaz, Camila
    Nachar, Ruben
    Ramirez-Mahaluf, Juan Pablo
    Gonzalez-Valderrama, Alfonso
    Undurraga, Juan
    Maccabe, James H.
    Crossley, Nicolas A.
    SCHIZOPHRENIA RESEARCH, 2021, 235 : 102 - 108
  • [36] Treatment-resistant schizophrenia: Clinical experience with new antipsychotics
    Bondolfi, G
    Baumann, P
    Dufour, H
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 1996, 6 : 21 - 25
  • [37] Clozapine induces metformin-resistant prediabetes/diabetes that is associated with poor clinical efficacy in patients with early treatment-resistant schizophrenia
    Zhuo, Chuanjun
    Xu, Yong
    Wang, Haibo
    Zhou, Chunhua
    Liu, Jian
    Yu, Xiaocui
    Shao, Hailin
    Tian, Hongjun
    Fang, Tao
    Li, Qianchen
    Chen, Jiayue
    Xu, Shuli
    Ma, Xiaoyan
    Yang, Weiliang
    Yao, Cong
    Li, Bo
    Yang, Anqu
    Chen, Yuhui
    Huang, Guoyong
    Lin, Chongguang
    JOURNAL OF AFFECTIVE DISORDERS, 2021, 295 : 163 - 172
  • [38] An investigation into the relationship between clozapine treatment and cognitive performance in patients with treatment resistant schizophrenia
    McArdle, P. A.
    De Mel, V.
    DeMonte, V.
    Winckel, K.
    Gore-Jones, V.
    Foley, S.
    Korman, N.
    Parker, S.
    Dark, F.
    Siskind, D.
    SCHIZOPHRENIA RESEARCH, 2019, 206 : 450 - 451
  • [39] Dopamine supersensitivity psychosis and delay of clozapine treatment in patients with treatment-resistant schizophrenia
    Masumo, Yuto
    Kanahara, Nobuhisa
    Kogure, Masanobu
    Yamasaki, Fumiaki
    Nakata, Yusuke
    Iyo, Masaomi
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2023, 38 (02) : 102 - 109
  • [40] Association between the examination rate of treatment-resistant schizophrenia and the clozapine prescription rate in a nationwide dissemination and implementation study
    Yasui-Furukori, Norio
    Muraoka, Hiroyuki
    Hasegawa, Naomi
    Ochi, Shinichiro
    Numata, Shusuke
    Hori, Hikaru
    Hishimoto, Akitoyo
    Onitsuka, Toshiaki
    Ohi, Kazutaka
    Hashimoto, Naoki
    Nagasawa, Tatsuya
    Takaesu, Yoshikazu
    Inagaki, Takahiko
    Tagata, Hiromi
    Tsuboi, Takashi
    Kubota, Chika
    Furihata, Ryuji
    Iga, Jun-ichi
    Iida, Hitoshi
    Miura, Kenichiro
    Matsumoto, Junya
    Yamada, Hisashi
    Watanabe, Koichiro
    Inada, Ken
    Shimoda, Kazutaka
    Hashimoto, Ryota
    NEUROPSYCHOPHARMACOLOGY REPORTS, 2022, 42 (01) : 3 - 9
12345